XML 37 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quaterly Financial Information (Unaudited) (Notes)
12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information
Quarterly Financial Information (Unaudited)
The following financial information reflects all normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the results of the interim periods. Summarized quarterly data for fiscal 2015 and 2014 are as follows (in thousands, except per share data):
 
 
1st
Quarter
 
2nd
Quarter
 
3rd
Quarter
 
4th
Quarter
Fiscal 2015 (1)
 
 
 
 
 
 
 
 
Revenues
 
$
13,839

 
$
15,547

 
$
15,862

 
$
15,578

Gross profit
 
$
3,648

 
$
4,767

 
$
4,802

 
$
4,692

Income from operations
 
$
165

 
$
1,163

 
$
948

 
$
498

Net income (3)
 
$
745

 
$
1,097

 
$
19,120

 
$
678

Net income per common share—basic (5)
 
$
0.04

 
$
0.06

 
$
0.99

 
$
0.03

Net income per common share—diluted (5)
 
$
0.04

 
$
0.06

 
$
0.97

 
$
0.03

 
 
 
 
 
 
 
 
 
Fiscal 2014 (2)
 
 
 
 
 
 
 
 
Revenues
 
$
12,997

 
$
14,587

 
$
13,881

 
$
14,143

Gross profit
 
$
3,442

 
$
4,505

 
$
4,409

 
$
4,284

Income (loss) from operations (4)
 
$
(155
)
 
$
825

 
$
1,032

 
$
816

Net income (loss)
 
$
(148
)
 
$
823

 
$
1,028

 
$
772

Net income (loss) per common share—basic (5)
 
$
(0.01
)
 
$
0.04

 
$
0.06

 
$
0.04

Net income (loss) per common share—diluted (5)
 
$
(0.01
)
 
$
0.04

 
$
0.05

 
$
0.04

(1) 
On March 5, 2015, we acquired MD Office Solutions (MD Office). The results of MD Office are included in Diagnostic Services since the acquisition date (See Note 3).  
(2) 
On March 13, 2014, we acquired 100% of the membership interest of Telerhythmics, LLC. The results of Telerhythmics are included in Diagnostic Services since the acquisition date (See Note 3).
(3) 
Included in net income for the third quarter of 2015 is an income tax benefit of $18.2 million primarily related to the release of the valuation allowance associated with a portion of our deferred tax assets.
(4) 
Included in the income (loss) from operations for the first, second, third, and fourth quarter of 2014, are approximately $0.4 million, $0.1 million, $0.1 million, and less than $0.1 million of charges, respectively, associated with our Diagnostic Imaging and Facilities restructuring initiatives (See Note 11).
(5) 
Earnings per share are computed independently for each of the quarters presented. Therefore, the sum of the quarterly net earnings per share will not necessarily equal the total for the year.